Brief: First Wave Biopharma Doses Second Patient In Phase 2 Trial Of Cystic Fibrosis Drug

GridAI Technologies

10/03/2023 14:16

March 10 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA ANNOUNCES SECOND PATIENT DOSED IN
PHASE 2
SPAN CLINICAL TRIAL OF ENHANCED ADRULIPASE FORMULATION IN CYSTIC
FIBROSIS
    * FIRST WAVE BIOPHARMA INC - TOPLINE RESULTS FROM STUDY ARE
ANTICIPATED BY MID-2023

Source text for Eikon:  ID:nGNX77VGsj 
Further company coverage:  FWBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))